Vigeo Therapeutics

Vigeo Therapeutics

Biotechnology, 545 Concord Ave, Cambridge, , 2138, Massachusetts, United States, 1-10 Employees

vigeotherapeutics.com

  • twitter
  • LinkedIn

Who is VIGEO THERAPEUTICS

Vigeo Therapeutics is a clinical stage company developing novel therapeutic agents for the treatment of cancer.

Read More

map
  • 545 Concord Ave, Cambridge, Massachusetts, 2138, United States Headquarters: 545 Concord Ave, Cambridge, Massachusetts, 2138, United States
  • 2011 Date Founded: 2011
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from VIGEO THERAPEUTICS

Vigeo Therapeutics Org Chart and Mapping

Employees

Aurelia Mickunas

Senior R&D Project Manager

Judy Chiao

Senior Vice President Clinical Development

Suming Wang

Associate Director, Translational Sciences

Jing Watnick

CEO, President, Board Director

Harold Pestana

Head of Clinical Operations

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Vigeo Therapeutics

Answer: Vigeo Therapeutics's headquarters are located at 545 Concord Ave, Cambridge, , 2138, Massachusetts, United States

Answer: Vigeo Therapeutics's official website is https://vigeotherapeutics.com

Answer: Vigeo Therapeutics's revenue is $1 Million to $5 Million

Answer: Vigeo Therapeutics's SIC: 2834

Answer: Vigeo Therapeutics's NAICS: 325412

Answer: Vigeo Therapeutics has 1-10 employees

Answer: Vigeo Therapeutics is in Biotechnology

Answer: Vigeo Therapeutics contact info: Phone number: Website: https://vigeotherapeutics.com

Answer: Vigeo Therapeutics is a clinical stage company developing novel therapeutic agents for the treatment of cancer.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access